We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
-1.68%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.43B
AUM Growth
+$172M
Cap. Flow
+$215M
Cap. Flow %
15.04%
Top 10 Hldgs %
3.57%
Holding
2,136
New
582
Increased
568
Reduced
423
Closed
559

Top Buys

Rank Stock Value
1
DVN icon
Devon Energy
DVN
+$5.97M
2
FISV
Fiserv Inc
FISV
+$5.03M
3
GPC icon
Genuine Parts
GPC
+$4.22M
4
TRI icon
Thomson Reuters
TRI
+$4.1M
5
VGR
Vector Group Ltd.
VGR
+$4.09M

Top Sells

Rank Stock Value
1
JBSS icon
John B. Sanfilippo & Son
JBSS
+$3.41M
2
APA icon
APA Corp
APA
+$3.31M
3
ZTS icon
Zoetis
ZTS
+$3.2M
4
UGI icon
UGI
UGI
+$3.03M
5
DOCU
DocuSign
DOCU
+$2.87M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Healthcare 13.4%
3 Consumer Discretionary 13.25%
4 Financials 12.49%
5 Industrials 11.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TELA icon
1526
TELA Bio
TELA
$38.9M
$106K 0.01%
22,493
-1,892
-8% -$9.97K
LONA
1527
LeonaBio Inc
LONA
$72.1M
$104K 0.01%
3,932
-13,691
-78% -$323K
TTI icon
1528
TETRA Technologies
TTI
$1.26B
$103K 0.01%
29,651
-122,496
-81% -$489K
DLTH icon
1529
Duluth Holdings
DLTH
$159M
$99K 0.01%
+26,938
New +$114K
RYAM icon
1530
Rayonier Advanced Materials
RYAM
$610M
$97K 0.01%
+17,771
New +$86.4K
GLUE icon
1531
Monte Rosa Therapeutics
GLUE
$1.35B
$95K 0.01%
+25,346
New +$129K
UFI icon
1532
UNIFI
UFI
$134M
$94K 0.01%
15,879
-19,890
-56% -$118K
CONN
1533
DELISTED
Conn's Inc.
CONN
$93K 0.01%
+83,933
New +$270K
OVID icon
1534
Ovid Therapeutics
OVID
$491M
$92K 0.01%
+119,507
New +$333K
PIII icon
1535
P3 Health Partners
PIII
$38.5M
$91K 0.01%
4,029
-7,281
-64% -$217K
OMER icon
1536
Omeros
OMER
$959M
$87K 0.01%
21,482
-273
-1% -$975
NPKI
1537
NPK International
NPKI
$1.14B
$87K 0.01%
10,478
-315,252
-97% -$2.43M
STIM icon
1538
Neuronetics
STIM
$166M
$86K 0.01%
+47,805
New +$138K
VMD icon
1539
Viemed Healthcare
VMD
$371M
$85K 0.01%
+13,007
New +$98K
SCYX icon
1540
SCYNEXIS
SCYX
$52M
$84K 0.01%
5,272
+2,335
+80% +$36.1K
MGTX icon
1541
MeiraGTx Holdings
MGTX
$1.21B
$83K 0.01%
+19,774
New +$99.8K
CTKB icon
1542
Cytek Biosciences
CTKB
$546M
$82K 0.01%
+14,647
New +$88K
DDL
1543
Dingdong
DDL
$503M
$80K 0.01%
40,083
-12,015
-23% -$20.1K
TUSK icon
1544
Mammoth Energy Services
TUSK
$163M
$80K 0.01%
+24,478
New +$84K
BDTX icon
1545
Black Diamond Therapeutics
BDTX
$112M
$78K 0.01%
+16,814
New +$90.3K
CRDF icon
1546
Cardiff Oncology
CRDF
$77.2M
$78K 0.01%
+35,037
New +$132K
WDH
1547
Waterdrop
WDH
$359M
$76K 0.01%
+67,601
New +$85.1K
LDI icon
1548
loanDepot
LDI
$516M
$74K 0.01%
+44,621
New +$95.2K
SEER icon
1549
Seer Inc
SEER
$120M
$73K 0.01%
43,353
-23,740
-35% -$44.3K
TUYA
1550
Tuya Inc
TUYA
$1.1B
$72K 0.01%
+41,885
New +$76.1K
60 61
62
63 64

Similar funds

NCL
Nishkama Capital LLC Dorado, Puerto Rico $1.58B AUM 123.32% 1-Year Est. Return
DG
DigitalBridge Group Boca Raton, Florida $1.58B AUM 62.54% 1-Year Est. Return
VNT
Vanguard National Trust Malvern, Pennsylvania $1.59B AUM
SS
Sunbelt Securities Houston, Texas $1.58B AUM 28.96% 1-Year Est. Return
GWANC
Guardian Wealth Advisors (North Carolina) Raleigh, North Carolina $1.59B AUM 15.17% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
LCM
Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return
FDCP
Foster Dykema Cabot & Partners Waltham, Massachusetts $1.57B AUM 20.41% 1-Year Est. Return

GSA Capital Partners's Q2 2024 Portfolio in Review

As of Q2 2024, GSA Capital Partners held 2,136 positions worth $1.43B, up 14% from $1.26B the previous quarter. Its ten largest holdings account for 3.6% of the portfolio.

GSA Capital Partners deployed $215M of net new capital in Q2 2024, opening 582 new positions and adding to 568 existing holdings. Its largest new stake was Genuine Parts: 28,253 shares worth $3.91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 16% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was UGI, an estimated $3.03M trimmed.

  • GSA Capital Partners's largest Q2 2024 buy was Genuine Parts: 28,253 shares worth $3.91M.
  • GSA Capital Partners added most to Devon Energy in Q2 2024, an estimated $5.97M increase.
  • GSA Capital Partners's biggest Q2 2024 reduction was UGI, cutting an estimated $3.03M.
  • GSA Capital Partners fully exited John B. Sanfilippo & Son in Q2 2024, selling an estimated $3.41M.
  • GSA Capital Partners's ten largest holdings make up 3.6% of its $1.43B portfolio in Q2 2024.
  • GSA Capital Partners opened 582 new positions and closed 559 in Q2 2024.
  • GSA Capital Partners's portfolio value rose 14% quarter-over-quarter to $1.43B.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.